Medi-Caps Board of Directors
Get the latest insights into the leadership at Medi-Caps. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Gajendra Singh | Ind. Non-Executive Director |
| Mr. Ramesh Chandra Mittal | Chairman & Non-Exe.Director |
| Mr. Alok K Garg | Managing Director |
| Mrs. Kusum Mittal | Non Executive Woman Director |
| Mr. Dharmendra Solanki | Ind. Non-Executive Director |
| Mr. Ashok Omprakash Agrawal | Ind. Non-Executive Director |
Medi-Caps Share price
MEDICAPQ
39
1.40 (-3.47%)Last updated on 31 Oct, 2025 | 15:29 IST
BUYSELL
Today's High
40.00
Today's Low
38.16
52 Week Low
34.32
52 Week High
61.00
The current prices are delayed, login to your account for live prices
LoginMedi-Caps FAQs
The board at Medi-Caps consists of experienced professionals, including Mr. Gajendra Singh , Mr. Ramesh Chandra Mittal , and others, overseeing the company’s strategic and corporate governance.
Directors at Medi-Caps are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Gajendra Singh is the current chairman at Medi-Caps.
Executive directors at Medi-Caps are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Medi-Caps adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Medi-Caps, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.